LALPATHLAB

Dr. Lal Pathlabs Share PriceDr. Lal Pathlabs

₹2015.2
9.85 (0.49%)
  • Advice
  • Hold
As on 04 June, 2023 | 03:24 BSE: 539524 NSE: LALPATHLAB

Dr. Lal Pathlabs Performance

Day Range

  • Low
  • High
2015.2

52 Week Range

  • Low
  • High
2015.2
  • Open Price
  • Previous Close
  • Volume

Start SIP in Dr. Lal Pathlabs

Start SIP

Dr. Lal Pathlabs Share Price

  • Over 1 Month 3.01%
  • Over 3 Month 1.73%
  • Over 6 Month -18.68%
  • Over 1 Year -5.98%

Dr. Lal Pathlabs Key Statistics

P/E Ratio 70.3
PEG Ratio -2.3
Market Cap Cr 16,809
Price to Book Ratio 9.9
EPS 35.1
Dividend 0.6
Relative Strength Index 54.76
Money Flow Index 56.83
MACD Signal 28.12
Average True Range 50.05

Dr. Lal Pathlabs Investment Rating

  • Master Rating:
  • Dr Lal Pathlabs has an operating revenue of Rs. 2,016.90 Cr. on a trailing 12-month basis. An annual revenue de-growth of -4% needs improvement, Pre-tax margin of 17% is great, ROE of 14% is good. The company has a reasonable debt to equity of 5%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 60 which is a FAIR score but needs to improve its earnings, a RS Rating of 29 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 151 indicates it belongs to a poor industry group of Medical-Services and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Dr. Lal Pathlabs Financials
IndicatorMar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 431428467439415
Operating Expenses Qtr Cr 315324337330310
Operating Profit Qtr Cr 116104130109105
Depreciation Qtr Cr 2121211922
Interest Qtr Cr 8810811
Tax Qtr Cr 2722282220
Net Profit Qtr Cr 7162798065

Dr. Lal Pathlabs Technicals

EMA & SMA

Current Price
₹2015.2
9.85 (0.49%)
  • Bullish Moving Average
  • ___
  • 8
  • Bearish Moving Average
  • ___
  • 8
  • 20 Day
  • ₹1999.94
  • 50 Day
  • ₹1972.27
  • 100 Day
  • ₹2017.29
  • 200 Day
  • ₹2155.14
  • 20 Day
  • ₹2000.11
  • 50 Day
  • ₹1927.01
  • 100 Day
  • ₹1969.69
  • 200 Day
  • ₹2206.38

Dr. Lal Pathlabs Resistance and Support

PIVOT
₹2020.42
Resistance
First Resistance ₹2040.94
Second Resistance ₹2076.52
Third Resistance ₹2097.04
RSI 54.76
MFI 56.83
MACD Single Line 28.12
MACD 25.33
Support
First Resistance ₹1984.84
Second Resistance ₹1964.32
Third Resistance ₹1928.74

Dr. Lal Pathlabs Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 175,303 8,964,995 51.14
Week 140,610 6,849,113 48.71
1 Month 216,170 6,636,418 30.7
6 Month 226,311 7,153,688 31.61

Dr. Lal Pathlabs Result Highlights

Dr. Lal Pathlabs Synopsis

NSE-Medical-Services

Dr. Lal Pathlabs Ltd is involved in the business activities of Other human health activities. Company’s Total Operating Revenue is Rs. 1769.00 Cr. and Equity Capital is Rs. 83.40 Cr. for the Year ended 31/03/2023. Dr. Lal Pathlabs Ltd. is a Public Limited Listed company incorporated on 14/02/1995 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L74899DL1995PLC065388 and registration number is 065388.
Market Cap 16,809
Sales 1,766
Shares in Float 3.75
No of funds 282
Yield 0.6
Book Value 9.95
U/D Vol ratio 1.2
LTDebt / Equity 5
Alpha -0.02
Beta 0.47

Dr. Lal Pathlabs

Owner NameMar-23Dec-22Sep-22Jun-22
Promoters 55.03%55.05%55.05%55.05%
Mutual Funds 3.26%2.71%2.76%2.83%
Insurance Companies 2.28%2.37%2.33%2.46%
Foreign Portfolio Investors 23.06%23.8%23.26%22.37%
Financial Institutions/ Banks
Individual Investors 9.5%9.02%8.23%10.44%
Others 6.87%7.05%8.37%6.85%

Dr. Lal Pathlabs Management

Name Designation
Brig.(Hony) Dr. Arvind Lal Executive Chairman
Dr. Om Prakash Manchanda Managing Director
Dr. Vandana Lal Executive Director
Mr. Rahul Sharma Non Executive Director
Mr. Anoop Mahendra Singh Independent Director
Mr. Sunil Varma Lead Independent Director
Mr. Harneet Singh Chandhoke Independent Director
Dr. Saurabh Srivastava Independent Director
Mrs. Somya Satsangi Independent Director
Dr. Archana Lal Erdmann Non Executive Director

Dr. Lal Pathlabs Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Dr. Lal Pathlabs Corporate Action

Date Purpose Remarks
2023-05-11 Audited Results & Final Dividend
2023-02-02 Quarterly Results
2022-11-08 Quarterly Results
2022-07-28 Quarterly Results & Interim Dividend
2022-05-17 Audited Results & Final Dividend
Date Purpose Remarks
2022-08-09 INTERIM Rs.6.00 per share(60%)Interim Dividend
2022-06-23 FINAL Rs.6.00 per share(60%)Final Dividend
2021-08-22 INTERIM Rs.6.00 per share(60%)Interim Dividend
2021-07-22 FINAL Rs.8.00 per share(80%)Final Dividend
2021-02-10 INTERIM Rs.6.00 per share (60%) Second Interim Dividend

Dr. Lal Pathlabs MF Shareholding

Name Amount(cr)
UTI Flexi Cap Fund Regular Plan Growth 24237
Kotak Equity Arbitrage Fund Growth 20587
Kotak Equity Opportunities Fund Growth 12514
Edelweiss Balanced Advantage Fund Regular Plan Growth 8907
Axis Growth Opportunities Fund Regular Growth 8377

Dr. Lal Pathlabs FAQs

What is Share Price of Dr. Lal Pathlabs ?

Dr. Lal Pathlabs share price is ₹2015 As on 04 June, 2023 | 03:10

What is the Market Cap of Dr. Lal Pathlabs ?

The Market Cap of Dr. Lal Pathlabs is ₹16808.6 Cr As on 04 June, 2023 | 03:10

What is the P/E ratio of Dr. Lal Pathlabs ?

The P/E ratio of Dr. Lal Pathlabs is 70.3 As on 04 June, 2023 | 03:10

What is the PB ratio of Dr. Lal Pathlabs ?

The PB ratio of Dr. Lal Pathlabs is 9.9 As on 04 June, 2023 | 03:10

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number